(Q52287975)

28 April 2018

title

Sociodemographic disparities in access to addiction treatment among a cohort of Vancouver injection drug users. (English)

1 reference

28 April 2018

1 reference

3

1 reference

28 April 2018

David C. Marsh

4

1 reference

28 April 2018

Martin T. Schechter

5

1 reference

28 April 2018

Robert S Hogg

6

1 reference

28 April 2018

Julio Montaner

7

object named as

Julio S G Montaner

1 reference

28 April 2018

Thomas Kerr

8

object named as

Thomas Kerr

1 reference

28 April 2018

Evan Wood

1

object named as

Evan Wood

1 reference

28 April 2018

author name string

Kathy Li

2

1 reference

28 April 2018

publication date

1 January 2005

1 reference

28 April 2018

published in

Substance Use and Misuse

1 reference

28 April 2018

volume

40

1 reference

28 April 2018

issue

8

1 reference

28 April 2018

page(s)

1153-1167

1 reference

28 April 2018

Cost-benefit and cost-effectiveness analysis of drug abuse treatment services.

cites work

1 reference

https://api.crossref.org/works/10.1081%2FJA-200042287

Science and health policy: can they cohabit or should they divorce?

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJA-200042287

Needle exchange, pragmatism, and moralism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJA-200042287

HIV incidence among injecting drug users in New York City syringe-exchange programmes

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJA-200042287

Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJA-200042287

A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJA-200042287

Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJA-200042287

Risk-taking behaviors among injecting drug users who obtain syringes from pharmacies, fixed sites, and mobile van needle exchanges

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJA-200042287

Epidemiology and the politics of needle exchange.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJA-200042287

The social determinants of emergency department and hospital use by injection drug users in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJA-200042287

Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJA-200042287

Do needle exchange programmes increase the spread of HIV among injection drug users?: an investigation of the Vancouver outbreak.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJA-200042287

Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJA-200042287

Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJA-200042287

Needle exchange is not enough: lessons from the Vancouver injecting drug use study

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJA-200042287

Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJA-200042287

The role of epidemiology in needle exchange programs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJA-200042287

Social costs of untreated opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJA-200042287

Drug treatment on demand--not.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJA-200042287

The potential public health and community impacts of safer injecting facilities: evidence from a cohort of injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJA-200042287

Prevalence and correlates of untreated human immunodeficiency virus type 1 infection among persons who have died in the era of modern antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJA-200042287

Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJA-200042287

Needle exchange and difficulty with needle access during an ongoing HIV epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJA-200042287

Rationale for evaluating North America's first medically supervised safer-injecting facility

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJA-200042287

21 January 2018

Identifiers

DOI

10.1081/JA-200042287

1 reference

28 April 2018

release_uz7aekec4fduho6tii3zuzyvve

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uz7aekec4fduho6tii3zuzyvve

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

28 April 2018